Roca Suarez AA, Plissonnier ML, Grand X, Michelet M, et al. TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism. Gut 2024 May 2:gutjnl-2023-331396. doi: 10.1136/gutjnl-2023-331396.
PMID: 38697771